Search results
Pfizer's chief scientist Mikael Dolsten to step down - ET HealthWorld | Pharma
The Economic Times· 2 days agoDolsten, aged 65, served as the head of Pfizer's research and development after he joined the...
Pfizer research chief Dolsten to step down, with company at a crossroads
BioPharma Dive· 3 days agoThe company has begun searching for a successor to Dolsten, who oversaw more than 35 drug and...